Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Current Medical Research and Opinion|January 21, 2021
Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory dataStephen J Freedland, Xuehua Ke, Marie-Hélène Lafeuille, et al.
American Journal of Clinical Pathology|October 19, 2021
Successful Implementation of a Rapid Screening Tool for Hantavirus Cardiopulmonary Syndrome: 5 Years of Experience From a Community Hospital in an Endemic RegionTarrah T Oliver, Jonathan W Dyal, Donna L Talker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moonR Latagliata, V Bongarzoni, I Carmosino, et al.
Emotion (Washington, D.C.)|September 6, 2019
Hurts so good: Pain as an emotion regulation strategyAshley M Doukas, Wendy M D'Andrea, Wesley E Gregory, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatmentsChau T Dang, Andrew J Dannenberg, Kotha Subbaramaiah, et al.
Microbiology Spectrum|January 26, 2022
Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus InfectionNoemi Poerio, Camilla Riva, Tommaso Olimpieri, et al.
Cell|July 21, 2021
Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathwayCharles L Evavold, Iva Hafner-Bratkovič, Pascal Devant, et al.
Spinal Cord|May 24, 2000
Walking index for spinal cord injury (WISCI): an international multicenter validity and reliability studyJ F Ditunno, P L Ditunno, V Graziani, et al.
Clinical Breast Cancer|May 19, 2005
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxaneShanu Modi, Violante E Currie, Andrew D Seidman, et al.
The Pharmacogenomics Journal|October 22, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatinE Cecchin, G Perrone, S Nobili, et al.
Pageof 13